PepsiCo reports declining North American snack and beverage volumes amid rising GLP-1 drug adoption and healthier eating trends, prompting investor scrutiny despite competitor gains.
PepsiCo exceeded Wall Street estimates with 8.5% revenue growth driven by snack price cuts and stable soda demand. Management navigated rising raw material costs and geopolitical risks while reaffirmi
PepsiCo faces pressure from activist investor Elliott to validate its cost-cutting strategy amid declining volumes. Rising costs for packaging materials like PET resin and LPG threaten margins despite
ChemBrief